Elvitegravir
Elvitegravir (JTK-303) is an HIV integrase strand transfer inhibitor used in antiviral research. It also acts as an inducer of cytochrome P450 2C9. This small molecule is applied in both in vitro enzymatic assays and in vivo models for studying HIV-1 replication and drug metabolism pathways.
Product Specifications
CAS Number
697761-98-1
Product Name Alternative
D 06677, D06677, D-06677, cDNA, Elvitegravir, EVG, GS9137, GS-9137, GS 9137, Inhibitor, Human immunodeficiency virus, HIV, HIV Integrase, HIV Protease, HIV-1 IIIB, HIV-1IIIB, HIV-2 EHO, HIV-2 ROD, HIV-2EHO, HIV-2ROD, HIVProtease, JTK 303, JTK303, JTK-303, inhibit
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
98.35% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.37 mM) ; DMSO:82 mg/mL (183.08 mM) ; Ethanol:33 mg/mL (73.68 mM)
Smiles
COC1=C (CC2=CC=CC (Cl) =C2F) C=C2C (=O) C (=CN (C (CO) C (C) C) C2=C1) C (O) =O
Molecular Formula
C23H23ClFNO5
Molecular Weight
447.88
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
